A citation-based method for searching scientific literature

Hans-Georg Wirsching, Patrick Roth, Michael Weller. Expert Opin Ther Targets 2021
Times Cited: 3







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.
David A Reardon, Morris D Groves, Patrick Y Wen, Louis Nabors, Tom Mikkelsen, Steve Rosenfeld, Jeffrey Raizer, Jorge Barriuso, Roger E McLendon, A Benjamin Suttle,[...]. Clin Cancer Res 2013
64
66

Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.
Alisa Madalina Popescu, Oana Alexandru, Corina Brindusa, Stefana Oana Purcaru, Daniela Elise Tache, Ligia Gabriela Tataranu, Citto Taisescu, Anica Dricu. Int J Clin Exp Pathol 2015
24
66

Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.
Jayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, Yangming Ou, Kyrre E Emblem, Alona Muzikansky, Xuezhu Cai, Linda Douw, John G Evans, Jorg Dietrich,[...]. J Neurooncol 2017
33
66

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.
Elizabeth R Gerstner, April F Eichler, Scott R Plotkin, Jan Drappatz, Colin L Doyle, Lei Xu, Dan G Duda, Patrick Y Wen, Rakesh K Jain, Tracy T Batchelor. J Neurooncol 2011
66
66

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma.
Xuejiao Liu, Xiangyu Chen, Lin Shi, Qianqian Shan, Qiyu Cao, Chenglong Yue, Huan Li, Shengsheng Li, Jie Wang, Shangfeng Gao,[...]. J Exp Clin Cancer Res 2019
33
66

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
66

Cell signaling by receptor tyrosine kinases.
Mark A Lemmon, Joseph Schlessinger. Cell 2010
66

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Tracy T Batchelor, Paul Mulholland, Bart Neyns, L Burt Nabors, Mario Campone, Antje Wick, Warren Mason, Tom Mikkelsen, Surasak Phuphanich, Lynn S Ashby,[...]. J Clin Oncol 2013
325
66

Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.
Malgorzata Sielska, Piotr Przanowski, Maria Pasierbińska, Kamil Wojnicki, Katarzyna Poleszak, Bartosz Wojtas, Dominika Grzeganek, Aleksandra Ellert-Miklaszewska, Min-Chi Ku, Helmut Kettenmann,[...]. Br J Cancer 2020
4
33

Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
Wouter B L van den Bossche, Anne Kleijn, Charlotte E Teunissen, Jane S A Voerman, Cristina Teodosio, David P Noske, Jacques J M van Dongen, Clemens M F Dirven, Martine L M Lamfers. Neuro Oncol 2018
23
33

Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
Zongpu Zhang, Jianye Xu, Zihang Chen, Huizhi Wang, Hao Xue, Chunlei Yang, Qindong Guo, Yanhua Qi, Xiaofan Guo, Mingyu Qian,[...]. Cancer Immunol Res 2020
16
33

Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.
Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar, Giorgio Seano, Katharina Susek, Veronica Yu, Nisha Dalvie, Robin L Amelung, Meenal Datta, Jonathan W Song,[...]. Proc Natl Acad Sci U S A 2016
181
33

ADAM8 affects glioblastoma progression by regulating osteopontin-mediated angiogenesis.
Yu Li, Songbo Guo, Kai Zhao, Catharina Conrad, Caroline Driescher, Vanessa Rothbart, Uwe Schlomann, Helena Guerreiro, Miriam H Bopp, Alexander König,[...]. Biol Chem 2020
4
33

ADAM8 affects glioblastoma progression by regulating osteopontin-mediated angiogenesis.
Yu Li, Songbo Guo, Kai Zhao, Catharina Conrad, Caroline Driescher, Vanessa Rothbart, Uwe Schlomann, Helena Guerreiro, Miriam H Bopp, Alexander König,[...]. Biol Chem 2020
3
33

A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
Fadi Jacob, Ryan D Salinas, Daniel Y Zhang, Phuong T T Nguyen, Jordan G Schnoll, Samuel Zheng Hao Wong, Radhika Thokala, Saad Sheikh, Deeksha Saxena, Stefan Prokop,[...]. Cell 2020
183
33

Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice.
Alexander M Stessin, Mariano Guardia Clausi, Zirun Zhao, Hong Lin, Wei Hou, Zhao Jiang, Timothy Q Duong, Stella E Tsirka, Samuel Ryu. J Neurooncol 2020
6
33


Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.
A Ellert-Miklaszewska, P Wisniewski, M Kijewska, P Gajdanowicz, D Pszczolkowska, P Przanowski, M Dabrowski, M Maleszewska, B Kaminska. Oncogene 2016
48
33

Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype.
Nina Xue, Qin Zhou, Ming Ji, Jing Jin, Fangfang Lai, Ju Chen, Mengtian Zhang, Jing Jia, Huarong Yang, Jie Zhang,[...]. Sci Rep 2017
59
33

Glioma-mediated microglial activation promotes glioma proliferation and migration: roles of Na+/H+ exchanger isoform 1.
Wen Zhu, Karen E Carney, Victoria M Pigott, Lindsay M Falgoust, Paul A Clark, John S Kuo, Dandan Sun. Carcinogenesis 2016
47
33

Phagocytic glioblastoma-associated microglia and macrophages populate invading pseudopalisades.
Elena Saavedra-López, Meritxell Roig-Martínez, George P Cribaro, Paola V Casanova, José M Gallego, Ana Pérez-Vallés, Carlos Barcia. Brain Commun 2019
7
33

Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
Konrad Gabrusiewicz, Benjamin Rodriguez, Jun Wei, Yuuri Hashimoto, Luke M Healy, Sourindra N Maiti, Ginu Thomas, Shouhao Zhou, Qianghu Wang, Ahmed Elakkad,[...]. JCI Insight 2016
208
33

In Search for Reliable Markers of Glioma-Induced Polarization of Microglia.
Kacper A Walentynowicz, Natalia Ochocka, Maria Pasierbinska, Kamil Wojnicki, Karolina Stepniak, Jakub Mieczkowski, Iwona A Ciechomska, Bozena Kaminska. Front Immunol 2018
22
33

PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response.
Jie Li, Megan M Kaneda, Jun Ma, Ming Li, Ryan M Shepard, Kunal Patel, Tomoyuki Koga, Aaron Sarver, Frank Furnari, Beibei Xu,[...]. Proc Natl Acad Sci U S A 2021
3
33

Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Marko Gjorgjevski, Ricarda Hannen, Barbara Carl, Yu Li, Emilie Landmann, Malte Buchholz, Jörg W Bartsch, Christopher Nimsky. Biosci Rep 2019
21
33

Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages.
Hao-Yu Chuang, Yu-Kai Su, Heng-Wei Liu, Chao-Hsuan Chen, Shao-Chih Chiu, Der-Yang Cho, Shinn-Zong Lin, Yueh-Sheng Chen, Chien-Min Lin. J Clin Med 2019
25
33

LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages.
Wan-Ming Hu, Yuan-Zhong Yang, Tian-Zhi Zhang, Chang-Fei Qin, Xue-Nong Li. Front Med (Lausanne) 2020
6
33

Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
Michael Zhang, Gregor Hutter, Suzana A Kahn, Tej D Azad, Sharareh Gholamin, Chelsea Y Xu, Jie Liu, Achal S Achrol, Chase Richard, Pia Sommerkamp,[...]. PLoS One 2016
107
33

Reduction of CD200 expression in glioma cells enhances microglia activation and tumor growth.
Chih-Yen Wang, Yun-Ti Hsieh, Kuan-Min Fang, Chung-Shi Yang, Shun-Fen Tzeng. J Neurosci Res 2016
6
33

A Virus-Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy.
Xihui Gao, Sha Li, Fei Ding, Xinlong Liu, Yijing Wu, Jing Li, Jing Feng, Xinyuan Zhu, Chuan Zhang. Adv Mater 2021
7
33

Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Tong-Fei Li, Ke Li, Chao Wang, Xin Liu, Yu Wen, Yong-Hong Xu, Quan Zhang, Qiu-Ya Zhao, Ming Shao, Yan-Ze Li,[...]. J Control Release 2017
33
33

Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM).
Kianush Karimian-Jazi, Philipp Münch, Allen Alexander, Manuel Fischer, Kira Pfleiderer, Manuel Piechutta, Matthia A Karreman, Gergely M Solecki, Anna S Berghoff, Mirco Friedrich,[...]. Theranostics 2020
9
33

Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma.
Alexander P Landry, Michael Balas, Saira Alli, Julian Spears, Zsolt Zador. Sci Rep 2020
18
33

ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.
Jinlong Yin, Sung Soo Kim, Eunji Choi, Young Taek Oh, Weiwei Lin, Tae-Hoon Kim, Jason K Sa, Jun Hee Hong, Se Hwan Park, Hyung Joon Kwon,[...]. Nat Commun 2020
20
33

Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma.
Jennifer L Gardell, Lisa R Matsumoto, Harrison Chinn, Kole R DeGolier, Shannon A Kreuser, Brooke Prieskorn, Stephanie Balcaitis, Amira Davis, Richard G Ellenbogen, Courtney A Crane. J Immunother Cancer 2020
8
33

Microglia immunophenotyping in gliomas.
Laura Annovazzi, Marta Mellai, Enrica Bovio, Samanta Mazzetti, Bianca Pollo, Davide Schiffer. Oncol Lett 2018
26
33

Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.
L Lisi, G M P Ciotti, D Braun, S Kalinin, D Currò, C Dello Russo, A Coli, A Mangiola, C Anile, D L Feinstein,[...]. Neurosci Lett 2017
80
33

Repolarization of glioblastoma macrophage cells using non-agonistic Dectin-1 ligand encapsulating TLR-9 agonist: plausible role in regenerative medicine against brain tumor.
Rohit Kumar Tiwari, Sarika Singh, Chhedi Lal Gupta, Pratibha Pandey, Vipendra Kumar Singh, Uzma Sayyed, Rafia Shekh, Preeti Bajpai. Int J Neurosci 2021
4
33

Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.
Maisa C Takenaka, Galina Gabriely, Veit Rothhammer, Ivan D Mascanfroni, Michael A Wheeler, Chun-Cheih Chao, Cristina Gutiérrez-Vázquez, Jessica Kenison, Emily C Tjon, Andreia Barroso,[...]. Nat Neurosci 2019
139
33

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.
F Zhang, N N Parayath, C I Ene, S B Stephan, A L Koehne, M E Coon, E C Holland, M T Stephan. Nat Commun 2019
105
33

Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Aurobind Vidyarthi, Tapan Agnihotri, Nargis Khan, Sanpreet Singh, Manoj K Tewari, Bishan D Radotra, Deepyan Chatterjee, Javed N Agrewala. Cancer Immunol Immunother 2019
27
33

MerTK as a therapeutic target in glioblastoma.
Jing Wu, Lauren N Frady, Ryan E Bash, Stephanie M Cohen, Allison N Schorzman, Yu-Ting Su, David M Irvin, William C Zamboni, Xiaodong Wang, Stephen V Frye,[...]. Neuro Oncol 2018
32
33

Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
Sumit Mukherjee, Angela Fried, Rahman Hussaini, Richard White, Juliet Baidoo, Sri Yalamanchi, Probal Banerjee. J Exp Clin Cancer Res 2018
32
33

Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome.
María González-Tablas Pimenta, Álvaro Otero, Daniel Angel Arandia Guzman, Daniel Pascual-Argente, Laura Ruíz Martín, Pablo Sousa-Casasnovas, Andoni García-Martin, Juan Carlos Roa Montes de Oca, Javier Villaseñor-Ledezma, Luis Torres Carretero,[...]. Brain Pathol 2021
6
33

Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.
Florian Klemm, Roeltje R Maas, Robert L Bowman, Mara Kornete, Klara Soukup, Sina Nassiri, Jean-Philippe Brouland, Christine A Iacobuzio-Donahue, Cameron Brennan, Viviane Tabar,[...]. Cell 2020
137
33

Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma.
Susan Brandenburg, Kati Turkowski, Annett Mueller, Yordan T Radev, Sabine Seidlitz, Peter Vajkoczy. Immunol Res 2017
15
33

Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.
Changbin Zhu, Dana Mustafa, Ping-Pin Zheng, Marcel van der Weiden, Andrea Sacchetti, Maarten Brandt, Ihsan Chrifi, Dennie Tempel, Pieter J M Leenen, Dirk Jan Duncker,[...]. Neuro Oncol 2017
21
33

FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia.
Xu-Dong Guo, Juan Ji, Teng-Fei Xue, Yu-Qin Sun, Ruo-Bing Guo, Hong Cheng, Xiu-Lan Sun. Front Immunol 2020
10
33

M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma.
Marine M Leblond, Elodie A Pérès, Charly Helaine, Aurélie N Gérault, Damien Moulin, Clément Anfray, Didier Divoux, Edwige Petit, Myriam Bernaudin, Samuel Valable. Oncotarget 2017
42
33

SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway.
Shuai Han, Wei Zhen, Tongqi Guo, Jianjun Zou, Fuyong Li. J Exp Clin Cancer Res 2020
4
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.